http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-202216723-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60
filingDate 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d8f4602475535ccea20eda56052ea5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd9355c691cae60e02a164428d354b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e4d4f285c95682c4f1606aa0f3e1eb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81a996902234534c404989037e67bf68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffda9aead5ff6bc57ba54c991638d8cc
publicationDate 2022-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-202216723-A
titleOfInvention Manufacture of compounds and compositions for inhibiting the activity of shp2
abstract The present invention relates to a method for the manufacture of a compound of Formula I or a pharmaceutically acceptable salt, acid co-crystal, hydrate or other solvate thereof, said method comprising reacting a compound of the formula II with a compound of the formula III according to the following reaction scheme:n .n wherein LG, A, n, m and p are as defined in the Summary of the Invention, said manufacture including the manufacture and use of a compound of the formula VI:n ;n wherein Rn 1 is a secondary amino protecting group and Rn 5 is unsubstituted or substituted alkyl, unsubstituted or substituted cycloalkyl or unsubstituted or substituted aryl.
priorityDate 2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396226

Total number of triples: 23.